LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

28.4 1.03

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

27.93

Max

28.84

Põhinäitajad

By Trading Economics

Sissetulek

-187M

-136M

Müük

4.3M

244M

P/E

Sektori keskmine

9.117

66.845

Aktsiakasum

1.08

Kasumimarginaal

-55.871

Töötajad

293

EBITDA

-22M

52M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+45.91% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. mai 2026

Turustatistika

By TradingEconomics

Turukapital

117M

1.7B

Eelmine avamishind

27.37

Eelmine sulgemishind

28.4

Uudiste sentiment

By Acuity

38%

62%

124 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. märts 2026, 23:39 UTC

Kuumad aktsiad

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4. märts 2026, 23:20 UTC

Tulu

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4. märts 2026, 21:43 UTC

Tulu

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4. märts 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4. märts 2026, 23:33 UTC

Market Talk
Uudisväärsed sündmused

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4. märts 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4. märts 2026, 22:30 UTC

Tulu

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4. märts 2026, 22:13 UTC

Tulu

Vermilion Energy 4Q EPS C$2.86 >VET

4. märts 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4. märts 2026, 21:53 UTC

Tulu

Lithium Americas 4Q Rev $66.8M >LAC

4. märts 2026, 21:53 UTC

Tulu

Lithium Americas 4Q Loss/Shr 52c >LAC

4. märts 2026, 21:52 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:50 UTC

Tulu

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4. märts 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. märts 2026, 21:48 UTC

Tulu

Webull 4Q Rev $165.2M >BULL

4. märts 2026, 21:48 UTC

Tulu

Webull 4Q EPS 1c >BULL

4. märts 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. märts 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4. märts 2026, 21:40 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:36 UTC

Uudisväärsed sündmused

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4. märts 2026, 21:27 UTC

Tulu

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4. märts 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4. märts 2026, 21:16 UTC

Tulu

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q EPS $1.50 >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q Net $7.35B >AVGO

4. märts 2026, 21:15 UTC

Tulu

Broadcom 1Q Rev $19.31B >AVGO

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

45.91% tõus

12 kuu keskmine prognoos

Keskmine 41.25 USD  45.91%

Kõrge 62 USD

Madal 25 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

4

Osta

3

Hoia

1

Müü

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Very Strong Bearish Evidence

Sentiment

By Acuity

124 / 351 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat